Practical considerations for iron therapy in the management of anaemia in patients with chronic kidney disease

被引：14

作者：

Roger, Simon D. ^{[1
]}

机构：

[1] Gosford Hosp, Dept Renal Med, Gosford, NSW, Australia

来源：

CLINICAL KIDNEY JOURNAL | 2017年 / 10卷

关键词：

anaemia; CKD; ESRD; ESA; iron; ERYTHROPOIESIS-STIMULATING AGENTS; RANDOMIZED CONTROLLED-TRIAL; CHRONIC-RENAL-FAILURE; INTRAVENOUS IRON; ORAL IRON; HEMODIALYSIS-PATIENTS; DEFICIENCY ANEMIA; IV IRON; SERUM FERRITIN; SUCROSE;

D O I：

10.1093/ckj/sfx100

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Clinical practice guidelines provide both local and global recommendations for the use of iron therapy in the management of anaemia in patients with chronic kidney disease. However, physicians must interpret and adapt these guidelines to meet the specific needs of their individual patients. The recommendations must also be considered in the context of findings from more recently published clinical trials and observational studies.

引用

页码：9 / 15

页数：7

共 50 条

[31] Can the Response to Iron Therapy Be Predicted in Anemic Nondialysis Patients with Chronic Kidney Disease? [J].

Stancu, Simona ;

Barsan, Liliana ;

Stanciu, Ana ;

Mircescu, Gabriel .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (03) :409-416

[32] Hepcidin in chronic kidney disease: not an anaemia management tool, but promising as a cardiovascular biomarker [J].

van der Weerd, N. C. ;

Grooteman, M. P. C. ;

Nube, M. J. ;

ter Wee, P. M. ;

Swinkels, D. W. ;

Gaillard, C. A. J. M. .

NETHERLANDS JOURNAL OF MEDICINE, 2015, 73 (03) :108-118

[33] Iron management and exercise training in individuals with chronic kidney disease: lived experiences [J].

Lightfoot, Courtney J. ;

Greenwood, Sharlene A. ;

Asgari, Elham ;

Banerjee, Debasish ;

Bhandari, Sunil ;

Burton, James O. ;

Kalra, Philip A. ;

Mccafferty, Kieran ;

Oliveira, Benjamin A. ;

Reid, Chante ;

Swift, Pauline A. ;

Wheeler, David C. ;

Wilkinson, Thomas J. ;

Bramham, Kate ;

Smith, Alice C. .

CLINICAL KIDNEY JOURNAL, 2025, 18 (01)

[34] Challenging patient phenotypes in the management of anaemia of chronic kidney disease [J].

Pramod, Sheena ;

Goldfarb, David S. .

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (11)

[35] Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? [J].

Swinkels, Dorine W. ;

Wetzels, Jack F. M. .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (08) :250-2453

[36] Use of Intravenous Iron Supplementation in Chronic Kidney Disease An Update [J].

Macdougall, Iain C. ;

Geisser, Peter .

IRANIAN JOURNAL OF KIDNEY DISEASES, 2013, 7 (01) :9-22

[37] Erythropoiesis-independent effects of iron in chronic kidney disease [J].

Patino, Edwin ;

Akchurin, Oleh .

PEDIATRIC NEPHROLOGY, 2022, 37 (04) :777-788

[38] Darbepoetin alfa: a new therapy for the management of anaemia associated with chronic kidney disease [J].

Lindberg, J .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (08) :977-984

[39] Biomarkers of iron metabolism in chronic kidney disease [J].

Tomasz, Glogowski ;

Ewa, Wojtaszek ;

Jolanta, Malyszko .

INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (05) :935-944

[40] Measurement of iron status in chronic kidney disease [J].

Hayes, Wesley .

PEDIATRIC NEPHROLOGY, 2019, 34 (04) :605-613

← 1 2 3 4 5 →